Fiprotec 134 mg Spot On Solution for Medium Dogs
Fipronil
Last verified
Veterinary medicinal product: spot-on solution. Distribution category: AVM-GSL (Veterinary Medicines Regulations 2013, Schedule 3). Active substance: Fipronil.1
In short: questions and answers
- Does Fiprotec 134 mg Spot On Solution for Medium Dogs need a prescription?
- Over the counter. As stated in the registration decision.1
- Which animals is Fiprotec 134 mg Spot On Solution for Medium Dogs for?
- Dogs.1
- What is the active substance in Fiprotec 134 mg Spot On Solution for Medium Dogs?
- Fipronil. ATCvet code: QP53AX15.13
- What is the withdrawal period of Fiprotec 134 mg Spot On Solution for Medium Dogs according to the leaflet?
- No withdrawal period is set for this drug: it is not intended for food-producing animals.3
- Dispensing
- Over the counter1
AVM-GSL: Authorised Veterinary Medicine - General Sale List. No prescription is needed and it may be sold by any retailer.12
Supplied without a prescription. As stated in the registration decision.
- Animal species
- Dogs1
- Active substance
- Fipronil
- ATCvet code
- QP53AX153
- Manufacturer
- Marketing authorisation holder: Beaphar B.V.
Withdrawal period
No withdrawal period is set for this drug: it is not intended for food-producing animals.3
Summary of product characteristics
Composition
Each pipette of 0.134 ml contains:
Active substance: Fipronil 134.0 mg
Excipients:
| Qualitative composition of excipients and other constituents | Quantitative composition if that information is essential for proper administration of the veterinary medicinal product |
|---|---|
| Butylhydroxyanisole (E320) | 0.268 mg |
| Butylhydroxytoluene (E321) | 0.134 mg |
| Benzyl alcohol (E1519) | 381.900 mg |
| Diethylene glycol monoethyl ether |
Clear colourless to slightly yellow spot-on solution.
Pharmacological properties
4.1 ATCvet code: QP53AX15
4.2 Pharmacodynamics
Fipronil is an insecticide/acaricide in the phenylpyrazole family. It acts by inhibiting the GABA complex, binding to the chloride channel and thereby blocking pre- and post-synaptic transfer of chloride ions across the membrane. This results in uncontrolled activity of the central nervous system and death in insects and acarids.
4.3 Pharmacokinetics
After topical application of the veterinary medicinal product on the dog, absorption of fipronil through the skin is slight. Low levels of fipronil may be detected in the plasma, with a very high variability between individuals. After topical application, the veterinary medicinal product will spread from the site of treatment to cover the entire surface of the animal. A concentration gradient of fipronil is set up on the fur of the animal extending from the point of application to the peripheral areas (lumbar zones, flanks).
Fipronil is mainly metabolised to its sulfone derivative (RM1602), which also possesses insecticidal and acaricidal properties.
The concentrations of fipronil on the hair decrease with time.
Target species
Dogs weighing 10 to 20 kg
Indications
Treatment and prevention of flea infestations (Ctenocephalides felis) in dogs. The duration of protection against flea infestations is 5 weeks.
The veterinary medicinal product protects against new tick infestations (Dermacentor reticulatus, Rhipicephalus sanguineus) in dogs from day 7 to day 28 after application.
Dosage
Spot-on use. By topical application to the skin.
Dosage: Make sure you use the correct product, corresponding to the bodyweight of your dog.
• Use 1 pipette of 1.34 ml per dog weighing over 10 kg and up to 20 kg bodyweight.
The dosing rate is 6.7 – 13.4 mg fipronil per kg bodyweight.
In the absence of safety studies, the minimum treatment interval is four weeks. - Method of administration: Use the easy-peel corners to remove a pipette from its blister. Do not puncture the foil with scissors, knives or other sharp instruments, as this may damage the pipette inside.
Hold the pipette upright. Tap the narrow part of the pipette to ensure the contents are within the main body of the pipette. Cut off the top of the pipette with scissors.
Part the coat between the shoulder blades and at the base of the head until the skin is visible. Place the tip of the pipette on the skin and gently apply half of its contents onto the skin at both application sites.
Avoid applying the solution onto the fur and do not rub into the skin.
Care should be taken to avoid excessive wetting of the hair with the veterinary medicinal product since this will cause a sticky appearance of hairs at the treatment spot. However, should this occur, it will usually disappear within 24-48 hours post application.
Contraindications
Do not use on dogs less than 8 weeks old and/or weighing less than 2 kg.
Do not use on sick (e.g. systemic disease, fever) or convalescent animals.
Do not use in rabbits, as adverse reactions and even death could occur.
Do not use in cats, as this could lead to overdosing.
Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Adverse reactions
Dogs
Very rare (<1 animal / 10 000 animals treated, including isolated reports):
Hypersalivation¹; Vomiting
Application site skin discoloration², Application site alopecia², Application site pruritus², Application site erythema²
Pruritus, Alopecia
Hyperaesthesia³, Central nervous system depression³, Neurological signs³
Respiratory signs
¹ If licking occurs, a brief period of excessive salivation may be observed due mainly to the nature of the carrier.
² Transient
³ Reversible
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder, or its local representative, or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Warnings
Special precautions for safe use in the target species:
For external use only. Do not apply the veterinary medicinal product on wounds or damaged skin.
Avoid contact with the animal’s eyes. In case of accidental eye contact immediately and thoroughly flush the eyes with water.
Animals should be weighed accurately prior to treatment (see section 3.9).
It is important to make sure that the veterinary medicinal product is applied to an area where the animal cannot lick it off, and to make sure that animals do not lick each other following treatment.
The potential toxicity of the veterinary medicinal product for puppies less than 8 weeks of age in contact with a treated bitch is not documented. Use according to a benefit/risk assessment by the responsible veterinarian.
Do not overdose.
Special precautions to be taken by the person administering the veterinary medicinal product to animals:
Keep the pipettes in original packaging until ready for use and dispose of used pipettes immediately.
People with known hypersensitivity to fipronil or to any of the excipients (see section 2) should avoid contact with the veterinary medicinal product. Avoid contents coming into contact with the fingers. If this occurs, wash hands with soap and water.
This veterinary medicinal product can cause mucous membrane and eye irritation. Therefore, contact of the veterinary medicinal product with mouth and eyes should be avoided.
After accidental ocular exposure the eye should be rinsed carefully with plain water.
Ingestion of the veterinary medicinal product is harmful. Prevent children getting access to the pipettes and discard the used pipettes immediately after applying the veterinary medicinal product. In case of accidental ingestion, seek medical advice and show the package leaflet or the label to the doctor.
Treated animals should not be handled until the application site is dry, and children should not be allowed to play with treated animals until the application site is dry. It is therefore recommended that animals are not treated during the day, but should be treated during the early evening, and that recently treated animals should not be allowed to sleep with owners, especially children. Do not smoke, drink or eat during application.
Wash hands after use.
Special precautions for the protection of the environment:
Dogs should not be allowed to swim in watercourses for 2 days after application.
Fipronil may adversely affect aquatic organisms.
Other precautions:
The veterinary medicinal product may have adverse effects on painted, varnished or other household surfaces or furnishings.
3.11 Special restrictions for use and special conditions for use, including restrictions on the use of antimicrobial and antiparasitic veterinary medicinal products in order to limit the risk of development of resistance
Not applicable.
Use during pregnancy, lactation or lay
The safety of the veterinary medicinal product has not been established in pregnant or lactating bitches.
Pregnancy and lactation:
Laboratory studies using fipronil have not produced any evidence of teratogenic or fetotoxic effects.
Use only according to the benefit/risk assessment by the responsible veterinarian.
If animals are treated during the lactating period, see section 3.5.
Interactions
Do not use simultaneously with other flea products which are applied directly onto the animal.
Overdose
No adverse effects have been demonstrated in the tolerance studies carried out with 8-week-old puppies, growing dogs and dogs weighing about 2 kg treated once at five times the recommended dose. The risk of causing adverse events may however increase with overdosing. It is therefore recommended to always treat animals with the appropriate pipette size.
Special warnings
For optimal control of flea infestations in multi-pet households, all animals in the household should be treated with a suitable insecticide.
Fleas from pets often infest the animal's basket, bedding and regular resting areas such as carpets and soft furnishings which should be treated, in case of massive infestations and at the beginning of the control measures, with a suitable insecticide and vacuumed regularly.
No data on the effect of bathing/shampooing on the efficacy in dogs are available. Shampooing prior to or frequently after treatment may reduce veterinary medicinal product efficacy.
The veterinary medicinal product does not prevent ticks from attaching to the animal. In addition, efficacy against existing tick infestations has not been demonstrated. For this reason, transmission of infectious diseases cannot be excluded.
It is known that the veterinary medicinal product will protect against new tick infestations from day 7 to day 28 after application of the veterinary medicinal product. However, it is not known whether efficacy against new tick infestations persists beyond 4 weeks. Therefore, there may be gaps in protection from such infestations after subsequent re-applications of the veterinary medicinal product, even if the veterinary medicinal product is re-applied at the minimum interval of 4 weeks.
Withdrawal period
Not applicable.
Incompatibilities
In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.
Immediate packaging
A blue pipette is composed of a heat-formed shell (polypropylene and acrylonitrile methyl acrylate copolymer/cyclic olefin copolymer polypropylene/polypropylene) and a film (acrylonitrile methyl acrylate copolymer/aluminium/polyester).
1, 2, 3, 6 pipettes are packed in a cardboard box.
Or
A blue pipette is composed of a heat-formed shell (polypropylene/cyclic olefin copolymer/ethylene-vinyl alcohol copolymer / polypropylene) and a film (polyethylene terephthalate/ aluminium/polypropylene).
The blue pipette is enclosed in an aluminium blister (polyethylene/ polyamide/ aluminium/polyamide/polyethylene and polyamide/aluminium/polyethylene). 1, 2, 3, 4, 6 pipettes are packed in a cardboard box.
Not all pack sizes may be marketed.
Storage
Do not store above 25°C.
Keep pipette within blister and box until ready for use, in order to protect from light.
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 2 years. Shelf life after first opening the immediate packaging: use immediately.
Disposal of unused product
Medicines should not be disposed of via wastewater.
The veterinary medicinal product should not enter water courses as fipronil may be dangerous for fish and other aquatic organisms.
Use take-back schemes for the disposal of any unused veterinary medicinal product or waste materials derived thereof in accordance with local requirements and with any national collection systems applicable to the veterinary medicinal product concerned.
Additional information
Vm 41941/4002
8 DATE OF FIRST AUTHORISATION
08 August 2014
9 DATE OF THE LAST REVISION OF THE SUMMARY OF THE PRODUCT CHARACTERISTICS
February 2026
10 CLASSIFICATION OF VETERINARY MEDICINAL PRODUCT
Veterinary medicinal product not subject to prescription.
Find more product information by searching for the ‘Product Information Database’ on www.gov.uk.
Approved: 17 March 2026
Registration holder
Beaphar B.V.
Regulations
- Veterinary Medicines Regulations 2013 (SI 2013/2033), Schedule 32
Sources
- VMD Product Information Database: Fiprotec 134 mg Spot On Solution for Medium Dogs, 41941/4002
- The Veterinary Medicines Regulations 2013, Schedule 3 (categories of veterinary medicinal products)
- Summary of Product Characteristics: Fiprotec 134 mg Spot On Solution for Medium Dogs
Other products with the same active substance
- Alfamed 2.5 mg/ml Cutaneous Spray, Solution for Cats and Dogs
- Alfamed Fipronil 134 mg Spot-on Solution for Medium Dogs
- Alfamed Fipronil 2.5 mg/ml Cutaneous Spray, Solution for Cats and Dogs
- Alfamed Fipronil 268 mg Spot-on Solution for Large Dogs
- Alfamed Fipronil 402 mg Spot-on Solution for Very Large Dogs
- Alfamed Fipronil 50 mg Spot-on Solution for Cats
- Alfamed Fipronil 67 mg Spot-on Solution for Small Dogs
- Amflee 134 mg Spot-on Solution for Medium Dogs
- Amflee 2.5 mg/ml Cutaneous Spray, Solution for Cats and Dogs
- Amflee 268 mg Spot-on Solution for Large Dogs
- Amflee 402 mg Spot-on Solution for Extra Large Dogs
- Amflee 50 mg Spot-on Solution for Cats
All products with this active substance (95)
The same active substance in other countries
Spain
- ALFAMED 2,5 mg/ml SOLUCION PARA PULVERIZACION CUTANEA PARA GATOS Y PERROS
- AMFLEE 402 mg SOLUCION PARA UNCION DORSAL PUNTUAL PARA PERROS MUY GRANDES
- AMFLEE 67 mg SOLUCION PARA UNCION DORSAL PUNTUAL PARA PERROS PEQUEÑOS
- DIPTRON 134 mg SOLUCION PARA UNCION DORSAL PUNTUAL PARA PERROS MEDIANOS
- DIPTRON 268 mg SOLUCION PARA UNCION DORSAL PUNTUAL PARA PERROS GRANDES
All products with this active substance (39)
Poland
- Amflee 402 mg roztwór do nakrapiania dla psów
- Biopronil spot-on 134 mg roztwór do nakrapiania dla psów
- Biopronil spot-on 268 mg roztwór do nakrapiania dla psów.
- Biopronil spot-on 67 mg roztwór do nakrapiania dla psów
- Clearonil 134 mg roztwór do nakrapiania dla średnich psów
All products with this active substance (34)